Used primarily in pharmaceutical research, this compound serves as a key intermediate in the synthesis of various bioactive molecules. Its structure is particularly valuable in the development of drugs targeting neurological disorders, including anxiety and depression. The trifluoromethyl group enhances the compound's stability and bioavailability, making it a crucial component in the design of novel therapeutic agents. Additionally, it is explored in the creation of enzyme inhibitors, which can be pivotal in treating conditions like cancer and inflammatory diseases. Its unique properties also make it a candidate for use in medicinal chemistry for optimizing drug efficacy and safety profiles.